TransMedics Group, Inc. (TMDX)

US — Healthcare Sector
Peers: CLPT  DMTKQ  INSP  OM 

Automate Your Wheel Strategy on TMDX

With Tiblio's Option Bot, you can configure your own wheel strategy including TMDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TMDX
  • Rev/Share 15.6663
  • Book/Share 9.3799
  • PB 13.6995
  • Debt/Equity 1.4439
  • CurrentRatio 9.8575
  • ROIC 0.0916

 

  • MktCap 4380616400.0
  • FreeCF/Share 0.5117
  • PFCF 252.456
  • PE 60.8108
  • Debt/Assets 0.5158
  • DivYield 0
  • ROE 0.2802

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade TMDX JP Morgan Overweight Neutral $116 $75 Dec. 17, 2024
Initiation TMDX Robert W. Baird -- Outperform -- $200 Sept. 24, 2024
Initiation TMDX Needham -- Buy -- $208 Aug. 21, 2024

News

Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMDX
TMDX
Published: February 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 26, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132320&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMDX
TMDX CLASS ACTION NOTICE: TransMedics Group, Inc. Investors that Suffered Losses are Notified to Contact BFA Law before the April 15 Court Deadline (NASDAQ:TMDX)
TMDX
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in TransMedics , you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.

Read More
image for news TMDX CLASS ACTION NOTICE: TransMedics Group, Inc. Investors that Suffered Losses are Notified to Contact BFA Law before the April 15 Court Deadline (NASDAQ:TMDX)
TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
TMDX
Published: February 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TransMedics securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").

Read More
image for news TMDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
TransMedics: Data Points To A Miss On Low Expectations, Followed By Big Improvement
TMDX
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral

TransMedics is expected to report disappointing Q4 results, with industry data suggesting it will likely miss and come in at the low end of guidance. The company's Q3 performance was poor, underperforming in Heart, Lung, and Liver transplants, leading to a significant loss of investor confidence. Despite a challenging Q4, early signs indicate a stronger start to 2025, potentially allowing management to provide more optimistic guidance for the year. Yet, I think they'll take the conservative route.

Read More
image for news TransMedics: Data Points To A Miss On Low Expectations, Followed By Big Improvement
TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights – TMDX
TMDX
Published: February 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 26, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132277&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights – TMDX
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TMDX
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ:TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased TransMedics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TMDX
TMDX Shareholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action Against TransMedics Group, Inc.
TMDX
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired TransMedics Group, Inc. (NASDAQ: TMDX) securities between February 28, 2023 and January 10, 2025. TransMedics describes itself as a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states.

Read More
image for news TMDX Shareholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action Against TransMedics Group, Inc.
Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join – Contact Levi & Korsinsky
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132179&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against TransMedics Group, Inc. (TMDX) - April 15, 2025 Deadline to Join – Contact Levi & Korsinsky
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Group, Inc. Lawsuit - TMDX
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132159&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2025 in TransMedics Group, Inc. Lawsuit - TMDX
TMDX CLASS ACTION ALERT: TransMedics Group, Inc.'s 30% Stock Drop Triggers Securities Fraud Class Action; Contact BFA Law before April 15 Deadline
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ:TMDX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in TransMedics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.

Read More
image for news TMDX CLASS ACTION ALERT: TransMedics Group, Inc.'s 30% Stock Drop Triggers Securities Fraud Class Action; Contact BFA Law before April 15 Deadline
Investors who lost money on TransMedics Group, Inc.(TMDX) should contact Levi & Korsinsky about pending Class Action - TMDX
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132157&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Investors who lost money on TransMedics Group, Inc.(TMDX) should contact Levi & Korsinsky about pending Class Action - TMDX
TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132139&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
Contact Levi & Korsinsky by April 15, 2025 Deadline to Join Class Action Against TransMedics Group, Inc.(TMDX)
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132106&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Contact Levi & Korsinsky by April 15, 2025 Deadline to Join Class Action Against TransMedics Group, Inc.(TMDX)
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against TransMedics Group, Inc.
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 3, 2022, and February 3, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 15, 2025.

Read More
image for news The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against TransMedics Group, Inc.
Levi & Korsinsky Notifies Shareholders of TransMedics Group, Inc. (TMDX) of a Class Action Lawsuit and an Upcoming Deadline
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132026&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies Shareholders of TransMedics Group, Inc. (TMDX) of a Class Action Lawsuit and an Upcoming Deadline
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking - Hagens Berman
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

SAN FRANCISCO, CA / ACCESS Newswire / February 25, 2025 / A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ:TMDX), a medical technology company specializing in organ transplant therapy, alleging that the company and certain executives engaged in fraudulent practices and concealed safety issues. The suit, captioned Jewik v.

Read More
image for news TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking - Hagens Berman
TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=132020&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TMDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TMDX
Published: February 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TransMedics securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").

Read More
image for news TMDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TMDX
Published: February 25, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TransMedics investors who were adversely affected by alleged securities fraud between February 28, 2023 and January 10, 2025.

Read More
image for news TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131938&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news TransMedics Group, Inc. Class Action: Levi & Korsinsky Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX
TMDX REMINDER: Kessler Topaz Meltzer & Check, LLP Urges TMDX Investors with Losses to Contact the Firm
TMDX
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

RADNOR, Pa., Feb. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025.

Read More
image for news TMDX REMINDER: Kessler Topaz Meltzer & Check, LLP Urges TMDX Investors with Losses to Contact the Firm
Levi & Korsinsky Notifies Shareholders of TransMedics Group, Inc.(TMDX) of a Class Action Lawsuit and an Upcoming Deadline
TMDX
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131866&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies Shareholders of TransMedics Group, Inc.(TMDX) of a Class Action Lawsuit and an Upcoming Deadline
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TMDX
TMDX
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ:TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), of the important April 15, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased TransMedics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TMDX
Class Action Filed Against TransMedics Group, Inc. (TMDX) Seeking Recovery for Investors - Contact Levi & Korsinsky
TMDX
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131839&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against TransMedics Group, Inc. (TMDX) Seeking Recovery for Investors - Contact Levi & Korsinsky
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman
TMDX
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN FRANCISCO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant therapy, alleging that the company and certain executives engaged in fraudulent practices and concealed safety issues. The suit, captioned Jewik v.

Read More
image for news TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman
Levi & Korsinsky Notifies Shareholders of TransMedics Group, Inc.(TMDX) of a Class Action Lawsuit and an Upcoming Deadline
TMDX
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131834&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies Shareholders of TransMedics Group, Inc.(TMDX) of a Class Action Lawsuit and an Upcoming Deadline
Class Action Announcement for TransMedics Group, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against TransMedics Group, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
TMDX
Published: February 24, 2025 by: PRNewsWire
Sentiment: Neutral

RADNOR, Pa. , Feb. 24, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics") (NASDAQ: TMDX) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the "Class Period").

Read More
image for news Class Action Announcement for TransMedics Group, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against TransMedics Group, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
A Securities Fraud Lawsuit Has Been Filed Against TransMedics Group, Inc. And Investors With Losses Are Urged To Contact The Schall Law Firm
TMDX
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral

LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 3, 2022, and February 3, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 15, 2025.

Read More
image for news A Securities Fraud Lawsuit Has Been Filed Against TransMedics Group, Inc. And Investors With Losses Are Urged To Contact The Schall Law Firm
Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMDX
TMDX
Published: February 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=131738&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies TransMedics Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMDX
TMDX LEGAL DEADLINE: TransMedics Group Investors that Lost Money are Reminded of Pending Class Action – Contact BFA Law by April 15 Court Deadline (NASDAQ:TMDX)
TMDX
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in TransMedics , you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.

Read More
image for news TMDX LEGAL DEADLINE: TransMedics Group Investors that Lost Money are Reminded of Pending Class Action – Contact BFA Law by April 15 Court Deadline (NASDAQ:TMDX)

About TransMedics Group, Inc. (TMDX)

  • IPO Date 2019-05-02
  • Website https://www.transmedics.com
  • Industry Medical - Devices
  • CEO Waleed H. Hassanein
  • Employees 728

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.